Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • stupid_hobo73 stupid_hobo73 Dec 9, 2011 9:48 AM Flag

    here comes NanoString

    Not the first firm product to take a run at Oncotype Dx....probably not the last....interesting though.

    Nanostring makes a big deal out of the categories low risk, intermediate risk and high risk. In reality, OncoType results come in the form of a raw number score...not a range. A score of 25 on Oncotype is considered intermediate but it is really the point where chemo should strongly be considered. Below 25, statistically, is low. Either way, most women in intermediate and high are recommended chemo anyway. Low risk is the most useful category...ie you don't need chemo. Oncotype produced more low risk results than Nanostring in their own studies.

 
GHDX
28.84-0.30(-1.03%)Sep 23 4:00 PMEDT